Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.6K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

617
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
617
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

429
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
429
Decision Making01:20

Decision Making

1.0K
Decision-making is a fundamental cognitive process that involves evaluating alternatives and selecting among them. This process can range from simple choices, such as deciding what to wear, to complex decisions, like choosing a major in college or a career path. The complexity of the decision often dictates the approach we use, which can be broadly categorized into two types: automatic and controlled decision-making.
Automatic decision-making is fast, intuitive, and relies on gut feelings...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and exploratory evaluation of a prediction model for oral mucositis in patients receiving CapeOX chemotherapy: a multicenter retrospective study.

Scientific reports·2026
Same author

VEGF Is a Stronger Predictor of Depressive Symptoms than Other Inflammation Markers in People with HIV on Antiretroviral Therapy.

Viruses·2026
Same author

Effects of a Moisturizer and Emollient on the Stratum Corneum Assessed by Confocal Raman Spectroscopy in Patients With and Without Atopic Dermatitis: An Assessor-Blinded Prospective Cohort Study.

Health science reports·2026
Same author

Design and Analysis of Randomized Clinical Trials With Average Hazard: Practical Guidance and Tools for Implementation.

Statistics in medicine·2026
Same author

A novel survival prediction model after isolated surgical aortic valve replacement in the transcatheter aortic valve replacement era.

General thoracic and cardiovascular surgery·2026
Same author

Bereaved Caregiver Perspectives on Quality of Care at the End of Life Among Adolescents and Young Adults with Cancer.

Journal of palliative medicine·2026

Related Experiment Video

Updated: Feb 11, 2026

Comparing the Frequency Effect Between the Lexical Decision and Naming Tasks in Chinese
08:08

Comparing the Frequency Effect Between the Lexical Decision and Naming Tasks in Chinese

Published on: April 1, 2016

9.7K

Decision on performing interim analysis for comparative clinical trials.

Kyongsun Pak1, Susanna Jacobus2, Hajime Uno3

  • 1Kitasato University, School of Pharmacy, Department of Clinical Medicine (Biostatistics), 5-9-1 Shirokane, Minato-ku, Tokyo 108-0072, Japan.

Contemporary Clinical Trials Communications
|April 27, 2018
PubMed
Summary
This summary is machine-generated.

A new blinded data monitoring tool helps predict early trial termination in randomized-controlled trials. This tool reduces unnecessary interim analyses without impacting study size or power, saving resources.

Keywords:
Blinded analysisData monitoringEarly termination for futilityEarly termination for superiorityInterim analysis

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.5K

Related Experiment Videos

Last Updated: Feb 11, 2026

Comparing the Frequency Effect Between the Lexical Decision and Naming Tasks in Chinese
08:08

Comparing the Frequency Effect Between the Lexical Decision and Naming Tasks in Chinese

Published on: April 1, 2016

9.7K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.5K

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Medical Research

Background:

  • Interim analyses in randomized-controlled trials (RCTs) are crucial for early termination decisions based on superiority or futility.
  • Formal interim analyses typically require unblinding, potentially compromising study integrity.
  • Blinded data within RCTs contain valuable information for predicting treatment effects.

Purpose of the Study:

  • To develop and evaluate a blinded data monitoring tool for predicting early trial termination in RCTs.
  • To assess the tool's impact on trial size, power, and the number of interim analyses.
  • To provide investigators with a method to interpret blinded data for potential early cessation.

Main Methods:

  • Development of a blinded data monitoring tool for RCTs with binary endpoints.
  • Extensive simulation studies to evaluate the tool's performance under various scenarios.
  • Focus on trials with one planned interim analysis for superiority or futility.

Main Results:

  • The proposed monitoring tool effectively predicts interim analysis outcomes supporting early termination.
  • Implementation of the tool significantly reduces the expected number of interim analyses, especially with small treatment effects.
  • The tool does not negatively affect trial size, statistical power, or introduce bias in treatment effect estimation.

Conclusions:

  • The blinded data monitoring tool offers a valuable method for interpreting blinded data during RCTs.
  • It enables investigators to potentially skip unnecessary interim analyses, preserving study integrity.
  • This approach can lead to substantial savings in study resources and budget.